TriSalus Life Sciences Total Liabilities and Share Holders Equity 2021-2025 | TLSI

TriSalus Life Sciences total liabilities and share holders equity from 2021 to 2025. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.

TriSalus Life Sciences Total Liabilities and Share Holders Equity 2021-2025 | TLSI

TriSalus Life Sciences total liabilities and share holders equity from 2021 to 2025. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$220.2B
Boston Scientific (BSX)$157B
Stryker (SYK)$154B
EssilorLuxottica (ESLOY)$136.6B
Medtronic (MDT)$119.2B
Lonza Group Ag (LZAGY)$50.3B
Haleon (HLN)$44.4B
ResMed (RMD)$40.3B
GE HealthCare Technologies (GEHC)$35.5B
Agilent Technologies (A)$34.1B
Terumo (TRUMY)$25.8B
Koninklijke Philips (PHG)$25.2B
Insulet (PODD)$20.4B
Zimmer Biomet Holdings (ZBH)$19.3B
Baxter (BAX)$15B
Smith & Nephew SNATS (SNN)$13.9B
Sunny Optical Technology (SNPTF)$10.4B
Demant (WILYY)$8.6B
Bio-Rad Laboratories (BIO)$7.2B
Lantheus Holdings (LNTH)$5B
Perrigo (PRGO)$3.9B
Prestige Consumer Healthcare (PBH)$3.8B
Haemonetics (HAE)$3.6B
Envista Holdings (NVST)$3.5B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
ICU Medical (ICUI)$3.2B
LeMaitre Vascular (LMAT)$1.9B
QuidelOrtho (QDEL)$1.9B
AtriCure (ATRC)$1.6B
Acuren (TIC)$1.4B